PP
THC icon

Paloma Partners’s Tenet Healthcare THC Stock Holding History

Paloma Partners’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,170
Closed -$1.19M – 1011
2024
Q3 		$1.19M Buy
7,170
+839
+13% +$127K 0.03% 384
2024
Q2 		$842K Buy
6,331
+2,961
+88% +$356K 0.02% 562
2024
Q1 		$354K Buy
+3,370
New +$303K 0.02% 476
2022
Q4 		– Sell
-11,250
Closed -$580K – 1155
2022
Q3 		$580K Buy
+11,250
New +$668K 0.03% 440
2021
Q2 		– Sell
-47,053
Closed -$2.45M – 2267
2021
Q1 		$2.45M Buy
+47,053
New +$2.38M 0.05% 335
2020
Q4 		– Sell
-14,475
Closed -$355K – 2208
2020
Q3 		$355K Buy
14,475
+675
+5% +$17.2K 0.01% 1376
2020
Q2 		$250K Sell
13,800
-18,759
-58% -$370K ﹤0.01% 1571
2020
Q1 		$469K Sell
32,559
-37,149
-53% -$1.07M 0.03% 525
2019
Q4 		$2.65M Buy
+69,708
New +$2.09M 0.04% 474
2017
Q3 		– Sell
-20,839
Closed -$403K – 2422
2017
Q2 		$403K Buy
20,839
+1,357
+7% +$23.7K ﹤0.01% 1665
2017
Q1 		$345K Sell
19,482
-42,275
-68% -$784K ﹤0.01% 1698
2016
Q4 		$916K Buy
61,757
+1,543
+3% +$27.7K 0.01% 1227
2016
Q3 		$1.36M Sell
60,214
-15,355
-20% -$400K 0.02% 777
2016
Q2 		$2.09M Buy
75,569
+46,672
+162% +$1.38M 0.02% 688
2016
Q1 		$835K Buy
28,897
+5,019
+21% +$131K 0.01% 997
2015
Q4 		$723K Buy
23,878
+2,996
+14% +$98.3K 0.02% 826
2015
Q3 		$771K Sell
20,882
-37,581
-64% -$1.94M 0.02% 795
2015
Q2 		$3.38M Buy
58,463
+38,216
+189% +$1.95M 0.07% 274
2015
Q1 		$1M Buy
+20,247
New +$946K 0.03% 491
2014
Q2 		– Sell
-13,941
Closed -$597K – 1236
2014
Q1 		$597K Buy
13,941
+3,057
+28% +$135K 0.04% 342
2013
Q4 		$459K Buy
+10,884
New +$474K 0.02% 620
2013
Q3 		– Sell
-4,496
Closed -$207K – 1180
2013
Q2 		$207K Buy
+4,496
New +$201K 0.01% 890

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Paloma Partners's THC Position: Q4 2024 in Review

Paloma Partners sold out of Tenet Healthcare (THC) in Q4 2024, closing a stake of 7,170 shares — an estimated $1.19M sold.

Paloma Partners first reported a position in THC in Q2 2013 and held it in 22 quarters. The position peaked at $3.38M in Q2 2015. 578 funds tracked by Wall St. Rank hold THC as of Q4 2024.

  • Paloma Partners reported no remaining Tenet Healthcare position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 7,170 Tenet Healthcare shares in Q4 2024, an estimated $1.19M.
  • Paloma Partners first reported a position in Tenet Healthcare in Q2 2013 and held it in 22 quarters.
  • Paloma Partners's Tenet Healthcare position peaked at $3.38M in Q2 2015.
  • 578 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.